As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and Broadcom (NASDAQ: AVGO). To learn more, check ...

AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...

Though Isomorphic is burning through millions in R&D costs now, investors have high hopes for the potential of AI drug ...

Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...

Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.

Singapore researchers are using Google DeepMind’s AlphaFold to understand the intricate protein interactions at play in ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Marchant, who joined Primark in 2009, left after the company hired lawyers to investigate “an allegation made by an ...